Plasma MiR-19b, MiR-34a, and MiR-146a Expression in Patients With Type 2 Diabetes Mellitus and Cataract: A Pilot Study. Biomol Biomed 2024, 537–544. https://doi.org/10.17305/bb.2023.9933.